Search research articles
Contact Us
Filters
Showing results (451-460 of 521) with videos related to
Page
of 53
Sort By:
Arthritis Research & Therapy
|
April 3, 2016
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Roberta Ramonda, Antonio Marchesoni, Antonio Carletto, et al.
Advances in Therapy
|
March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Fernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Clinical and Experimental Rheumatology
|
January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
Salvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.
Frontiers in Immunology
|
July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Arthritis Research & Therapy
|
September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 22, 2021
Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study
Sonja E Leonhard, Cheng Yin Tan, Annemiek A van der Eijk, et al.
BMC Health Services Research
|
December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study
Emanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
BMC Rheumatology
|
September 11, 2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
Delia Colombo, Micol Frassi, Giusy Pagano Mariano, et al.
Women'S Health Reports (New Rochelle, N.Y.)
|
March 9, 2022
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A <i>Post Hoc</i> Gender Analysis
Delia Colombo, Micol Frassi, Giuseppa Pagano Mariano, et al.
Autoimmunity Reviews
|
July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
Page
of 53
Search research articles
Search
Showing results (451-460 of 521) with videos related to
Sort By:
Page
of 53
Arthritis Research & Therapy
|
April 3, 2016
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey
Roberta Ramonda, Antonio Marchesoni, Antonio Carletto, et al.
Advances in Therapy
|
March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease
Fernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Clinical and Experimental Rheumatology
|
January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
Salvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.
Frontiers in Immunology
|
July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Arthritis Research & Therapy
|
September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 22, 2021
Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study
Sonja E Leonhard, Cheng Yin Tan, Annemiek A van der Eijk, et al.
BMC Health Services Research
|
December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study
Emanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
BMC Rheumatology
|
September 11, 2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study
Delia Colombo, Micol Frassi, Giusy Pagano Mariano, et al.
Women'S Health Reports (New Rochelle, N.Y.)
|
March 9, 2022
The CHRONOS Real-World Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A <i>Post Hoc</i> Gender Analysis
Delia Colombo, Micol Frassi, Giuseppa Pagano Mariano, et al.
Autoimmunity Reviews
|
July 17, 2012
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
Fabiola Atzeni, Piercarlo Sarzi-Puttini, Costantino Botsios, et al.
Page
of 53